Piattaforma diagnostica in-vitro che esegue test di suscettibilità agli antibiotici in un'ora direttamente dal campione.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Seed Dutch ShanX Medtech closed an oversubscribed €15 million seed led by Borski Fund to clinically validate and launch its rapid diagnostics against antibiotic resistance. | $17.4M |